Archives: Agenda

During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within supply chain logistics for biopharmaceuticals.

ROUNDTABLE 1: Meeting sustainability targets for pharma supply chains

Kamal Amin, Head of Clinical Supplies Management, Galderma

ROUNDTABLE 2: Managing supply chain vendors to ensure smooth logistical operations

Luiz Barberini, Head of External Manufacturing, Latin America, Bayer

ROUNDTABLE 3: Re-engineering clinical trial supply chains: building faster, smarter and more resilient global operations

Chiara Venuti, Member of the Management Board, Cool Chain Association

ROUNDTABLE 4: Navigating CDMO Partnerships as a Small Biotech: Challenges and Practical Solutions

Amanda Brown, Clinical Trial Supply Manager, Immutep

• Balancing sustainability goals with performance requirements in cold chain packaging design
• Selecting the right passive and active packaging solutions for your product
• Gaining flexibility in the supply chain through partnership and collaboration in packaging operations

• Positioning cold chain integrity as a patient safety issue, not just a logistics function
• Acknowledging EMEA diversity and moving beyond one-size-fits-all approaches
• Applying risk-based, data-driven decision-making across the supply chain
• Strengthening governance through empowered local quality teams

• IOT and Technology Evolution
• From Reactivity to Proactively saving shipments.
• AI in predictability – The Next frontier

• Understanding the unique challenges of cryogenic and ultra low temperature shipments
• Selecting the right packaging, carriers and monitoring tools to ensure product integrity
• Planning for lane validation, dry ice replenishment and contingency protocols for global routes

• Exploring opportunities to build collaborative relationships with suppliers in order to reduce costs and environmental impact
• Sharing practices as a method to streamline logistical operations for pharmaceutical products
• Assessing the role of vendors and CMOs in increasing collaboration across the industry
• Understanding restrictions and limitations: when does collaborating and sharing resources not work?
• Improving the Trust among players

How pharma logistics companies are implementing CMM across their global networks

• Examples of real CMM implementations in GDP
• What worked (and what failed)
• The concrete business value it brought
• Learnings and pitfalls to account for

• Shifting (bio)pharma shipments from air to ocean to improve costs, carbon footprint and temperature integrity
• Managing longer transit times through integrated, end-to-end logistics and asset control
• Reducing temperature excursions and power-off risks across multi-leg journeys
• Improving schedule reliability and visibility through a single, trusted logistics partner